hpv vaccination for cancer prevention
TRANSCRIPT
HPV Vaccination for Cancer Prevention
February 27, 2020
Pamela C. Hull, Ph.D.Rural Healthcare Providers Symposium
Collaborators and Partners
Vanderbilt University Medical CenterDebra Friedman, MDStephen Deppen, PhDTatsuki Koyama, PhDLiping Du, PhDCaree McAfee, MA, CHESJaimie Shing, MAJessica Jones, MSKelsey Minix, MPHAlyssa RentuzaJuan Canedo, DHSc
Vanderbilt UniversityShelagh Mulvaney, PhD
Meharry-Vanderbilt-TSU
Cancer PartnershipMeharry Medical CollegeMaureen Sanderson, PhD
Tennessee State UniversityElizabeth Williams, PhD
Cumberland Pediatric FoundationLora Harnack, MSNJanet CatesChristine Stroebel, MPH
Community PartnersMVTCP Community Advisory Board HPV Cancer Free Tennessee CoalitionTN Department of HealthProgreso Community Center
Supported by NIH grant numbers: R01CA207401, U54CA163072, U54CA163066, U54CA163069,
3P30CA068485-18S3, UL1 RR024975, UL1 TR000445, and VU Trans-Institutional Programs
Infections cause some cancers
Hepatitis C virus
Hepatitis B virus
Helicobacter pylori
HPV (human papillomavirus)
Courtesy of Krystle Kuhs, PhD
Data from Viens et al. MMWR 2016. https://www.cdc.gov/cancer/hpv/statistics
70%
91%
91%
69%
63%
75% HPV causes a large burden of cancers, pre-cancers, and
genital warts
% Attributed to HPV
Epidemic of HPV Oropharyngeal Cancer
Oropharynx (Overall)
HPV-positive Oropharynx
HPV-negative Oropharynx
10
1
Rat
es p
er
10
0,0
00
Calendar Years
HPV
Tobacco & Alcohol
225% Increase
Chaturvedi et al, J Clin Onc, 2011Courtesy of Krystle Kuhs, PhD
Oropharynx
Gillison Vaccine 2012; headandneckcancerguide.org
1 new case of HPV-related cancerevery 20 minutes
Screening is only available for cervical cancer
6-12 months after 1st dose 2 & 6 months after 1st dose
Routine HPV vaccination recommended for both males and females at ages 11 – 12 years
*Late: 13-26 years
MMWR 2016;65(49) 1405-1408 http://dx.doi.org/10.15585/mmwr.mm6549a5
Human Papilloma Virus (HPV) Vaccination
70%
48%
59%
45%45%
31%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
1+ Dose All Doses
Urban Suburban Rural/Town
*
Healthy People 2020 Goal: 80% Series Completion
*
*
* Significantly lower than
Urban at p<0.05
Source: 2018 NIS-Teen Data
Tennessee, 2018
HPV Vaccination: Challenges
17% increase in HPV vaccination during well visits
2.5-fold increase in providers using evidence-based
“announcement” communication
Baseline Follow UpResults
30% Increase in Bundling HPV Vaccinewith Other Adolescent Vaccines
Available Materials: Co-brand with your logo
MagnetFront & Back of Clinic Flyer (space for logo)
SPANISH
Billboard
Request: get3shots.org
TN Dept of Health:
Video
Print ads
Social media
Bus wraps
Request: [email protected]
https://www.youtube.com/watch?v=PfgS31AfGvs
Supplemental Slide for Q&A
